▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Motley Fool Staff

the_motley_fool

Recent Articles by Motley Fool Staff

20181102_IF_Tech_thumb_03

Nov 7, 2018 by Motley Fool Staff

Breaking Down Apple's Fiscal Fourth Quarter

The tech titan is revamping its financial reporting while guiding to a mediocre December quarter.

20181102_IF_Tech_thumb_02

Nov 7, 2018 by Motley Fool Staff

Spotify Intended to Lose More Money

The dominant paid-music streamer wants to be hiring more.

20181102_IF_Tech_thumb_01

Nov 7, 2018 by Motley Fool Staff

Fitbit's Smartwatch Transition Brings Return to Profitability

Fitibt has spent the past year ramping up its smartwatch business, and it’s now starting to pay off.

Motley_Fool_Answers_10_30_2018_thumb_10

Nov 7, 2018 by Motley Fool Staff

Too Much Netflix Stock Is a Great Problem to Have

A listener has been investing in the video streamer for a while, but thanks to its huge gains, it now accounts for around half his portfolio. Whatever should he do?

Rule_Breaker_Investing_10_24_2018_thumb_03

Nov 8, 2018 by Motley Fool Staff

What Kind of Genius CEO Says “We Suck” About His Own Company?

An incredibly successful one, it turns out. Because it all depends on how you measure, and this media disruptor has some high standards.

Motley_Fool_Answers_10_30_2018_thumb_09

Nov 6, 2018 by Motley Fool Staff

Financial Goals for Your 20s: How the Heck Do You Save for All of This?

When you’re young, married, and trying to follow all the personal-finance guidelines, it can seem overwhelming.

Motley_Fool_Answers_10_30_2018_thumb_08

Nov 6, 2018 by Motley Fool Staff

When Warren Buffett Retires, What Will Happen to Berkshire Hathaway Stock?

The Oracle of Omaha’s investing genius is part of what makes his company great. But it’s only part.

Motley_Fool_Answers_10_30_2018_thumb_07

Nov 6, 2018 by Motley Fool Staff

How Much of Your Portfolio Should Be in International Stocks?

Popular answers range from 50% to zero.

Motley_Fool_Answers_10_30_2018_thumb_06

Nov 6, 2018 by Motley Fool Staff

Could the US Dollar Lose Its Reserve Currency Primacy?

And what would happen to the value of tech stocks if it did?

Motley_Fool_Answers_10_30_2018_thumb_05

Nov 6, 2018 by Motley Fool Staff

How Risky Are Bond Funds Today?

The traditional view of bonds as safe places to stash money you'll soon need to access doesn't square with the current rising-interest-rate environment.

Motley_Fool_Answers_10_30_2018_thumb_04

Nov 6, 2018 by Motley Fool Staff

Why Is a High Valuation in One Industry a Low One in Another?

And how do fundamentals like inflation and interest rates factor into the investment value equation?

Motley_Fool_Answers_10_30_2018_thumb_03

Nov 6, 2018 by Motley Fool Staff

Is There an Index Fund Stock Bubble?

Passive investing has become so popular, some top investors worry that it's inflating the value of many stocks.

Motley_Fool_Answers_10_30_2018_thumb_02

Nov 6, 2018 by Motley Fool Staff

How Much Apple Stock Is Too Much Apple Stock?

Many retail investors have the iPhone giant in their individual portfolios. But Apple's an extremely common mutual fund holding, too, which can leave them overexposed to its ups and downs.

Rule_Breaker_Investing_10.24.2018_thumb

Nov 2, 2018 by Motley Fool Staff

Great Quotes Vol. 9: Pursued by a Bear

From investing luminaries to picture books, and back to the bosom of the Bard.

20181031_IF_Healthcare_thumb_05

Nov 2, 2018 by Motley Fool Staff

Here's What to Do Before the Next Big Market Drop

The stock market's recent correction is a great reminder of how important it is to be prepared for the inevitable down days.

20181031_IF_Healthcare_thumb_04

Nov 2, 2018 by Motley Fool Staff

Incyte's Shares Have Taken a Beating in 2018 -- Here's Why

Here's what we can learn from the failure of Incyte's highly-touted cancer therapy.

20181031_IF_Healthcare_thumb_03

Nov 2, 2018 by Motley Fool Staff

What We Can Learn From Synergy Pharmaceuticals' Disastrous News

The revelation that this biotech may be on borrowed time is a great reminder to investors to analyze balance sheets.

20181031_IF_Healthcare_thumb_02

Nov 2, 2018 by Motley Fool Staff

How Geron's Horrible Year Is a Great Reminder to Investors

Here are some lessons learned from a major setback that derailed its shares this year.

20181031_IF_Healthcare_thumb_01

Nov 2, 2018 by Motley Fool Staff

Here's What You Should Know About Stock Market Corrections

Menacing markets are frightening, but they're also common.

MF10302018_thumb_03

Nov 1, 2018 by Motley Fool Staff

Why Isn't a Rising Tide Lifting BP, Too?

Third-quarter profits were the highest in five years, but the stock price doesn't reflect that.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services